![Hamid Erfanian](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hamid Erfanian
Amministratore Delegato presso Enzo Clinical Labs, Inc.
Patrimonio netto: 428 549 $ in data 30/06/2024
Posizioni attive di Hamid Erfanian
Società | Posizione | Inizio | Fine |
---|---|---|---|
Enzo Life Sciences (ELS) AG
![]() Enzo Life Sciences (ELS) AG Miscellaneous Commercial ServicesCommercial Services Part of Enzo Biochem, Inc., Enzo Life Sciences (ELS) AG is a Swiss company that offers thousands of antibodies against peptides, whole or partial proteins, and modified peptides or proteins. Enzo Life Sciences is based in Lausen, Switzerland and offers a Worry-free Antibody Trial Program, expert technical support, and worldwide distributors. The company provides reagents to ensure that vaccines are first-to-market and cost-effective. | Presidente | - | - |
Enzo Clinical Labs, Inc.
![]() Enzo Clinical Labs, Inc. Medical/Nursing ServicesHealth Services Part of Enzo Biochem, Inc., Enzo Clinical Labs, Inc. is a clinical laboratory. The company is based in Farmingdale, NY. The CEO of the company is Hamid Erfanian. Enzo Clinical Labs was acquired by Laboratory Corp. of America Holdings from Enzo Biochem, Inc. on July 24, 2023 for $113.25 million. | Amministratore Delegato | - | - |
Storia della carriera di Hamid Erfanian
Precedenti posizioni note di Hamid Erfanian
Società | Posizione | Inizio | Fine |
---|---|---|---|
ENZO BIOCHEM, INC. | Direttore/Membro del Consiglio | 03/01/2022 | 05/09/2023 |
Amministratore Delegato | 08/11/2021 | 05/09/2023 | |
EUROIMMUN Medizinische Labordiagnostika AG
![]() EUROIMMUN Medizinische Labordiagnostika AG Medical SpecialtiesHealth Technology EUROIMMUN Medizinische Labordiagnostika AG is a holding company, which engages in the development and production of test systems and automation solutions for the laboratory diagnosis of autoimmune and infectious diseases, allergies, and gene analyses. The company was founded by Winfried Stöcker in September 1987 and is headquartered in Luebeck, Germany. | Corporate Officer/Principal | - | - |
Formazione di Hamid Erfanian
SMU-Cox School of Business | Masters Business Admin |
North Dakota State University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 5 |
Germania | 2 |
Svizzera | 2 |
Posizioni
Chief Executive Officer | 2 |
Director/Board Member | 1 |
Masters Business Admin | 1 |
Settori
Health Technology | 3 |
Consumer Services | 3 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
ENZO BIOCHEM, INC. | Health Technology |
Aziende private | 3 |
---|---|
EUROIMMUN Medizinische Labordiagnostika AG
![]() EUROIMMUN Medizinische Labordiagnostika AG Medical SpecialtiesHealth Technology EUROIMMUN Medizinische Labordiagnostika AG is a holding company, which engages in the development and production of test systems and automation solutions for the laboratory diagnosis of autoimmune and infectious diseases, allergies, and gene analyses. The company was founded by Winfried Stöcker in September 1987 and is headquartered in Luebeck, Germany. | Health Technology |
Enzo Life Sciences (ELS) AG
![]() Enzo Life Sciences (ELS) AG Miscellaneous Commercial ServicesCommercial Services Part of Enzo Biochem, Inc., Enzo Life Sciences (ELS) AG is a Swiss company that offers thousands of antibodies against peptides, whole or partial proteins, and modified peptides or proteins. Enzo Life Sciences is based in Lausen, Switzerland and offers a Worry-free Antibody Trial Program, expert technical support, and worldwide distributors. The company provides reagents to ensure that vaccines are first-to-market and cost-effective. | Commercial Services |
Enzo Clinical Labs, Inc.
![]() Enzo Clinical Labs, Inc. Medical/Nursing ServicesHealth Services Part of Enzo Biochem, Inc., Enzo Clinical Labs, Inc. is a clinical laboratory. The company is based in Farmingdale, NY. The CEO of the company is Hamid Erfanian. Enzo Clinical Labs was acquired by Laboratory Corp. of America Holdings from Enzo Biochem, Inc. on July 24, 2023 for $113.25 million. | Health Services |
- Borsa valori
- Insiders
- Hamid Erfanian
- Esperienza